Every investor has asked the question: Is what you’re building an aspirin or a vitamin?
The latest edition of What’s Next in Payments dives into how features that used to be vitamins are becoming table stakes overnight, and products that were once obvious painkillers are getting unbundled by AI agents that solve the same pain for free.